HER2 Support Group Forums - View Single Post

Lien · 04-04-2009, 06:54 AM

Well, if you'd run those path results for a 50 yr old woman through Adjuvant! you'd find that without further therapy she'd have a risk of relapse around 30%, and hormonal tx would roughly halve that risk. Additional chemo therapy could reduce the risk further by about 8 percent. So a recurrance risk of about 7 percent would remain.

In this estimation an AI was used and a 3d generation chemo regimen, like TAC or FEC times 6.

I have no idea whether the Oncotype score would change the Adjuvant estimates significantly.

Jacqueline

04-04-2009, 06:54 AM	#6
Lien Senior Member Join Date: May 2006 Location: Haarlem, the Netherlands Posts: 835	Well, if you'd run those path results for a 50 yr old woman through Adjuvant! you'd find that without further therapy she'd have a risk of relapse around 30%, and hormonal tx would roughly halve that risk. Additional chemo therapy could reduce the risk further by about 8 percent. So a recurrance risk of about 7 percent would remain. In this estimation an AI was used and a 3d generation chemo regimen, like TAC or FEC times 6. I have no idea whether the Oncotype score would change the Adjuvant estimates significantly. Jacqueline __________________ Diagnosed age 44, January 2004, 0.7 cm IDC & DCIS. Stage 1, grade 3, ER/PR pos. HER2 pos. clear margins, no nodes. SNB. 35 rads. On Zoladex and Armidex since Dec. 2004. Stopped Zoladex/Arimidex sept 2009 Still taking mistletoe shots (CAM therapy) Doing fine.